Fundly.ai | $4M (Pre-Series A)
Investorsync desk1 min read
Deal sheet
$4M
- Stage
- Pre-Series A
- Announced
- 12 September 2026
Founders: Amit Kumar Chawla, Shreeram V Ramanathan
Founded: 2021
HQ: Mumbai
Sector: PharmaTech / B2B Commerce & Embedded Finance
What they do
→ AI-native B2B platform connecting ordering, payments, settlement and embedded credit for pharma distribution
→ Replaces WhatsApp, phone calls, and paper ledgers with a unified digital layer
→ Serves 4,100+ retailers across 24 cities and 600+ pincodes
→ Payments infrastructure already live in a Pune pilot with ~3,000 retailers
The Funding
→ Raised $4M in a pre-Series A round
→ Co-led by existing investors Accel and Multiply Ventures
→ Participation from former RBL Bank executive director Rajeev Ahuja and other angels
→ Separately raised $900K in venture debt from Alteria Capital
→ Builds on a $3M seed round in 2023, taking total funding to over $7M
Why it matters
→ India's pharma distribution market is worth ₹2.5 lakh crore, spread across 70,000+ distributors and 1M+ retailers
→ Started as pure supply-chain financing before expanding into commerce and payments now building the full stack
→ Plans an intelligence layer over transaction data to improve demand forecasting and credit underwriting
→ Bets that fixing coordination, not just credit, is the real unlock in pharma distribution
Can fintech-style credit scoring actually work for something as fragmented as pharma retail?
Source: company announcement. First posted on the Investorsync LinkedIn page.
From InvestorDB